Literature DB >> 3882228

Double labeling of human leukemic cells using 3H-cytarabine and monoclonal antibody against bromodeoxyuridine.

A Raza, H D Preisler.   

Abstract

A new technique using immunofluorescence and autoradiography is described, in which the DNA of cells in S phase are labeled with two different probes. This method makes it possible to study the relationship between DNA synthesis and the uptake and/or incorporation of chemotherapeutic agents into normal or neoplastic cells. An example is provided in which the incorporation of 3H-cytarabine into DNA is demonstrated to occur only in cells which were synthesizing DNA during exposure to 3H-cytarabine. Other radioactively labeled probes can be used as well.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882228

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  3 in total

1.  Mitogenic effects of a mesothelial cell growth factor: evidence for a potential autocrine regulation of normal and malignant mesothelial cell proliferation.

Authors:  A Donna; P G Betta; M Ribotta; E Maran; G Mazzucco; F Mollo; D Bellingeri; R Libener
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

3.  Bone marrow cells in the DNA-synthesis-phase in the myelodysplastic syndrome and lymphome.

Authors:  A M Wenthzel; A Porwit; K Lindahl; S Widell; P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.